<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00885391</url>
  </required_header>
  <id_info>
    <org_study_id>060908</org_study_id>
    <secondary_id>R01HL085690-01A2</secondary_id>
    <nct_id>NCT00885391</nct_id>
  </id_info>
  <brief_title>QT Variability Pre and Post Cardioversion</brief_title>
  <acronym>DCCV</acronym>
  <official_title>QT Variability Pre &amp; Post Cardioversion in Patient's With Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn whether the chemicals in the blood and urine are
      different when the heart is atrial fibrillation compared to normal sinus rhythm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrial Fibrillation variably activates the renin-angiotensin-aldosterone system (RAAS),
      stimulates the sympathetic nervous system, generates oxidant stress, produces natriuretic
      peptides, and increases ventricular rate. These are interrelated responses and the extent to
      which these or other pathophysiologic responses determine QT interval during and after Atrial
      Fibrillation (AF) is unknown. In this study, the QT variability is related to those potential
      markers in patients with AF undergoing elective DC-cardioversion.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>QT variability before and after direct current cardioversion</measure>
    <time_frame>1.5</time_frame>
  </primary_outcome>
  <enrollment type="Actual">219</enrollment>
  <condition>Atrial Fibrillation</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiology Clinic Hospital inpatient
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 21 years of age

          -  Scheduled to undergo an elective DC-Cardioversion of atrial fibrillation or atrial
             flutter at Vanderbilt University Medical Center

        Exclusion Criteria:

          -  Undergoing emergent DC-Cardioversion of atrial fibrillation for hemodynamic
             instability

          -  Undergoing DC-Cardioversion for post-cardiac surgery

          -  Dual chamber pacemakers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dawood Darbar, M.D., Ph.D., F.A.C.C.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-0575</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2009</study_first_submitted>
  <study_first_submitted_qc>April 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2009</study_first_posted>
  <last_update_submitted>December 9, 2014</last_update_submitted>
  <last_update_submitted_qc>December 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Dawood Darbar</investigator_full_name>
    <investigator_title>Associate Professor of Medicine and Pharmacology</investigator_title>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Cardioversion</keyword>
  <keyword>Direct Current Cardioversion</keyword>
  <keyword>QT Interval</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

